Data as of Sep 19
| +0.56 / +0.76%|
The 30 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 70.71, with a high estimate of 97.63 and a low estimate of 50.65. The median estimate represents a -5.37% decrease from the last price of 74.72.
The current consensus among 31 polled investment analysts is to Hold stock in AstraZeneca PLC. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.